Brief: Illumina Advances MRD Research Portfolio With Ultrasensitive Duplex Sequencing Technology
BRIEF-Illumina Advances MRD Research Portfolio With Ultrasensitive Duplex Sequencing Technology Nov 9 (Reuters) - Illumina Inc ILMN.O:
ILLUMINA ADVANCES MRD RESEARCH PORTFOLIO WITH ULTRASENSITIVE DUPLEX SEQUENCING TECHNOLOGY
Source text: ID:nPn6VtN0ra
Further company coverage: ILMN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Illumina
See all newsBrief: Illumina Advances MRD Research Portfolio With Ultrasensitive Duplex Sequencing Technology
US STOCKS ON THE MOVE-Global Payments, Aspen Neuroscience, Illumina
U.S. STOCKS ON THE MOVE-FedEx Freight, AbbVie, Intel
Illumina falls on Q3 revenue miss
Illumina Inc reports results for the quarter ended September 30 - Earnings Summary